Matches in Wikidata for { <http://www.wikidata.org/entity/Q89234980> ?p ?o ?g. }
- Q89234980 description "2017 nî lūn-bûn" @default.
- Q89234980 description "2017年の論文" @default.
- Q89234980 description "2017年学术文章" @default.
- Q89234980 description "2017年学术文章" @default.
- Q89234980 description "2017年学术文章" @default.
- Q89234980 description "2017年学术文章" @default.
- Q89234980 description "2017年学术文章" @default.
- Q89234980 description "2017年学术文章" @default.
- Q89234980 description "2017年學術文章" @default.
- Q89234980 description "2017年學術文章" @default.
- Q89234980 description "2017年學術文章" @default.
- Q89234980 description "2017年學術文章" @default.
- Q89234980 description "2017年學術文章" @default.
- Q89234980 description "2017년 논문" @default.
- Q89234980 description "article científic" @default.
- Q89234980 description "article scientific" @default.
- Q89234980 description "article scientifique" @default.
- Q89234980 description "articol științific" @default.
- Q89234980 description "articolo scientifico" @default.
- Q89234980 description "artigo científico" @default.
- Q89234980 description "artigo científico" @default.
- Q89234980 description "artigo científico" @default.
- Q89234980 description "artikel ilmiah" @default.
- Q89234980 description "artikull shkencor" @default.
- Q89234980 description "artikulong pang-agham" @default.
- Q89234980 description "artykuł naukowy" @default.
- Q89234980 description "artículo científico publicado en 2017" @default.
- Q89234980 description "artículu científicu" @default.
- Q89234980 description "bilimsel makale" @default.
- Q89234980 description "bài báo khoa học" @default.
- Q89234980 description "naučni članak" @default.
- Q89234980 description "scienca artikolo" @default.
- Q89234980 description "scientific article published on 08 February 2017" @default.
- Q89234980 description "scientific article published on 8 February 2017" @default.
- Q89234980 description "scientific article published on 8 February 2017" @default.
- Q89234980 description "teaduslik artikkel" @default.
- Q89234980 description "tieteellinen artikkeli" @default.
- Q89234980 description "tudományos cikk" @default.
- Q89234980 description "vedecký článok" @default.
- Q89234980 description "vetenskaplig artikel" @default.
- Q89234980 description "videnskabelig artikel udgivet 8. februar 2017" @default.
- Q89234980 description "vitenskapelig artikkel" @default.
- Q89234980 description "vitskapeleg artikkel" @default.
- Q89234980 description "vědecký článek" @default.
- Q89234980 description "wetenschappelijk artikel" @default.
- Q89234980 description "wissenschaftlicher Artikel" @default.
- Q89234980 description "επιστημονικό άρθρο" @default.
- Q89234980 description "мақолаи илмӣ" @default.
- Q89234980 description "наукова стаття, опублікована в лютому 2017" @default.
- Q89234980 description "научна статия" @default.
- Q89234980 description "научная статья" @default.
- Q89234980 description "научни чланак" @default.
- Q89234980 description "научни чланак" @default.
- Q89234980 description "מאמר מדעי" @default.
- Q89234980 description "مقالة علمية نشرت في 8 فبراير 2017" @default.
- Q89234980 description "৮ ফেব্রুয়ারি ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q89234980 description "บทความทางวิทยาศาสตร์" @default.
- Q89234980 description "სამეცნიერო სტატია" @default.
- Q89234980 name "FDA Approval Summary: Pembrolizumab for the Treatment of Patients with Unresectable or Metastatic Melanoma" @default.
- Q89234980 name "FDA Approval Summary: Pembrolizumab for the Treatment of Patients with Unresectable or Metastatic Melanoma" @default.
- Q89234980 type Item @default.
- Q89234980 label "FDA Approval Summary: Pembrolizumab for the Treatment of Patients with Unresectable or Metastatic Melanoma" @default.
- Q89234980 label "FDA Approval Summary: Pembrolizumab for the Treatment of Patients with Unresectable or Metastatic Melanoma" @default.
- Q89234980 prefLabel "FDA Approval Summary: Pembrolizumab for the Treatment of Patients with Unresectable or Metastatic Melanoma" @default.
- Q89234980 prefLabel "FDA Approval Summary: Pembrolizumab for the Treatment of Patients with Unresectable or Metastatic Melanoma" @default.
- Q89234980 P1433 Q89234980-316280EE-650C-4AA4-ACA7-292D0C60DC1C @default.
- Q89234980 P1476 Q89234980-2514B38E-0FC1-417D-BAC8-962C802075CE @default.
- Q89234980 P2093 Q89234980-01759EED-40FA-4891-95F4-42EF3D9FE1F3 @default.
- Q89234980 P2093 Q89234980-14479054-C30A-41FA-B5B3-9569A3C79052 @default.
- Q89234980 P2093 Q89234980-1BBA9BD7-B7AC-497E-A378-F2BE78D34A5C @default.
- Q89234980 P2093 Q89234980-2649E675-824A-4169-B826-1F1809907B49 @default.
- Q89234980 P2093 Q89234980-2EEF3691-8FFB-4E5B-BC8D-41B6A256B009 @default.
- Q89234980 P2093 Q89234980-4C0CD8EC-C141-4924-A85C-2E3ED28A6924 @default.
- Q89234980 P2093 Q89234980-543CFBB5-BEB4-4954-A6DC-9F21D401C424 @default.
- Q89234980 P2093 Q89234980-9DF03811-D501-4CF1-993F-92F0C3B76F50 @default.
- Q89234980 P2093 Q89234980-AD4EE0BF-91E5-4504-8847-522E9583FF0F @default.
- Q89234980 P2093 Q89234980-B459E367-15DB-4083-BBDE-8D9C53FFD30C @default.
- Q89234980 P2093 Q89234980-B88966FD-4CFD-45F1-891F-ED55212CAED8 @default.
- Q89234980 P2093 Q89234980-D79DDF85-4159-42FD-850E-5BEC0751547F @default.
- Q89234980 P2093 Q89234980-E21DEA32-321B-405B-B4C1-A52B584F502D @default.
- Q89234980 P2093 Q89234980-E4BDA0B1-659A-4B59-B080-FC2DF851ADE4 @default.
- Q89234980 P2093 Q89234980-F38800E9-CA4E-495B-863F-DE36DC2C38C0 @default.
- Q89234980 P304 Q89234980-0AE121CE-21A2-425E-BD7F-8294E9D4E2C6 @default.
- Q89234980 P31 Q89234980-168A54E6-DA0D-4959-B2B8-5A3780635D46 @default.
- Q89234980 P356 Q89234980-D4A26677-634E-49B8-8EA3-8A924668BD38 @default.
- Q89234980 P433 Q89234980-1285B44B-3829-45FE-9BBA-4D79579C56BD @default.
- Q89234980 P478 Q89234980-179C2D6A-058E-4D52-BAB8-F0447E4BD649 @default.
- Q89234980 P577 Q89234980-E27B7781-2105-44EC-96BE-5E83999F35B4 @default.
- Q89234980 P698 Q89234980-B4118045-AC97-4E7A-A761-A524BFD4D715 @default.
- Q89234980 P921 Q89234980-95E442A3-2789-4B6F-BA75-B1ECFB506FCD @default.
- Q89234980 P921 Q89234980-E3A05CB3-0AB2-478B-B883-D4FD16DAA633 @default.
- Q89234980 P356 1078-0432.CCR-16-0664 @default.
- Q89234980 P698 28179454 @default.
- Q89234980 P1433 Q332253 @default.
- Q89234980 P1476 "FDA Approval Summary: Pembrolizumab for the Treatment of Patients with Unresectable or Metastatic Melanoma" @default.
- Q89234980 P2093 "Amy Barone" @default.
- Q89234980 P2093 "Elimika Pfuma" @default.
- Q89234980 P2093 "Hong Zhao" @default.
- Q89234980 P2093 "Hongshan Li" @default.
- Q89234980 P2093 "Huanyu Chen" @default.